Mindera Health files for $30.4M equity financing

What's the deal? Mindera Health has filed a Form D with the U.S. Securities and Exchange CommissionDealroom has a profile for this one. Try Dealroom → for an equity offering. The filing reports $30,439,738 sold as of July 14, 2026, including the mandatory conversion of approximately $29.4M in outstanding convertible promissory notes.

What it means. Mindera Health develops a dermal biomarker patch and molecular diagnostics platform to guide treatment decisions for skin conditions, including plaque psoriasis.

Why it matters. The filing indicates an equity financing, although it does not identify the investors. The notice permits up to $50.0M in total offering amount, of which $30.4M had been sold when filed.

Read more: SEC filing · Intelligence360

Image credit: Generated with Gemini